FDA Approved: DAPTOMYCIN — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approves a generic version of daptomycin under an Original Application (ANDA) from Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Complicated Skin and Skin Structure Infections
• Infective Endocarditis

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

ORIG AP for DAPTOMYCIN (DAPTOMYCIN)